Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» TherapeuticsMD shares drop 7% on new FDA review timeline for its drug
TherapeuticsMD shares drop 7% on new FDA review timeline for its drug
TherapeuticsMD shares drop 7% on new FDA review timeline for its drug
Submitted by
admin
on December 20, 2017 - 11:33am
Source:
Marketwatch
News Tags:
TherapeuticsMD
FDA
TX-004HR
Headline:
TherapeuticsMD shares drop 7% on new FDA review timeline for its drug
Do Not Allow Advertisers to Use My Personal information
